Yi Kong

1.2k total citations
31 papers, 918 citations indexed

About

Yi Kong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi Kong has authored 31 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Yi Kong's work include Hemoglobinopathies and Related Disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Iron Metabolism and Disorders (3 papers). Yi Kong is often cited by papers focused on Hemoglobinopathies and Related Disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Iron Metabolism and Disorders (3 papers). Yi Kong collaborates with scholars based in China, United States and Australia. Yi Kong's co-authors include Mitchell J. Weiss, Kazuhiko Adachi, Anthony J. Kihm, M. Celeste Simon, Gerd A. Blobel, Janice Russell, Hong Wei, Susan Rouda, Shuwen Liu and Chunping Gu and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Frontiers in Immunology.

In The Last Decade

Yi Kong

28 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Kong China	16	415	285	235	179	171	31	918
Barbara Peter Austria	21	417 1.0×	141 0.5×	135 0.6×	145 0.8×	66 0.4×	48	1.1k
Laura Ottaggio Italy	21	568 1.4×	228 0.8×	116 0.5×	83 0.5×	65 0.4×	53	1.1k
Estelle Saland France	18	902 2.2×	187 0.7×	461 2.0×	91 0.5×	63 0.4×	28	1.4k
Jaira F. de Vasconcellos United States	14	549 1.3×	195 0.7×	125 0.5×	40 0.2×	64 0.4×	33	910
Claudia Fiorini Italy	19	587 1.4×	133 0.5×	84 0.4×	51 0.3×	182 1.1×	26	1.1k
Prosenjit Sen India	18	393 0.9×	93 0.3×	249 1.1×	43 0.2×	47 0.3×	48	953
John M. Rumberger United States	14	602 1.5×	61 0.2×	183 0.8×	111 0.6×	205 1.2×	20	1.3k
Shuming Sun China	21	566 1.4×	73 0.3×	93 0.4×	60 0.3×	84 0.5×	51	959
RT Swank United States	21	331 0.8×	69 0.2×	316 1.3×	373 2.1×	164 1.0×	34	1.0k
Lyubov Zaitseva United Kingdom	20	1.1k 2.5×	343 1.2×	598 2.5×	52 0.3×	60 0.4×	28	1.7k

Countries citing papers authored by Yi Kong

Since Specialization

Citations

This map shows the geographic impact of Yi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Kong more than expected).

Fields of papers citing papers by Yi Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Kong. The network helps show where Yi Kong may publish in the future.

Co-authorship network of co-authors of Yi Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Kong. A scholar is included among the top collaborators of Yi Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Kong. Yi Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Yi, Jian Jiang, Yuqiong Huang, et al.. (2023). Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis. Frontiers in Immunology. 13. 1094375–1094375. 15 indexed citations

Zhang, Jiali, Zhengyang Li, Kaiyuan Zhang, et al.. (2022). Bifunctional fusion protein targeting both FXIIa and FXIa displays potent anticoagulation effects. Life Sciences. 309. 121021–121021. 4 indexed citations

Qian, Weidong, Xinchen Li, Min Yang, et al.. (2022). Relationship Between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Escherichia coli Isolates from Ningbo, China. Infection and Drug Resistance. Volume 15. 2865–2878. 20 indexed citations

Kong, Yi, et al.. (2021). A Novel Factor Xa-Inhibiting Peptide from Centipedes Venom. UNC Libraries.

Fang, Wei‐Jie, et al.. (2020). Protein Sub-Visible Particle and Free Radical formation of a Freeze-Dried Monoclonal Antibody Formulation During Dropping. Journal of Pharmaceutical Sciences. 110(4). 1625–1634. 7 indexed citations

Wang, Ying, et al.. (2019). The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling. UNC Libraries. 1 indexed citations

Darwanto, Agus, Anne-Mette K. Hein, Sascha Strauß, et al.. (2017). Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform. BMC Cancer. 17(1). 358–358. 14 indexed citations

Kong, Yi, Yan Zheng, Yanfei Jia, Ping Li, & Yunshan Wang. (2016). Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer. Oncology Reports. 36(4). 1852–1860. 25 indexed citations

Kong, Yi, Zhen Wang, Yanfei Jia, et al.. (2016). Effects of mutants in bHLH region on structure stability and protein-DNA binding energy in DECs. Journal of Biomolecular Structure and Dynamics. 35(9). 1849–1862. 4 indexed citations

10.

Kong, Yi, et al.. (2015). Celecoxib antagonizes the cytotoxicity of oxaliplatin in human esophageal cancer cells by impairing the drug influx. European Journal of Pharmaceutical Sciences. 81. 137–148. 8 indexed citations

11.

Tian, Ye, Yi Kong, Xiaojian Li, et al.. (2015). Light- and pH-activated intracellular drug release from polymeric mesoporous silica nanoparticles. Colloids and Surfaces B Biointerfaces. 134. 147–155. 22 indexed citations

12.

Jia, Yanfei, Dongjie Xiao, Xiaoli Ma, et al.. (2013). Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer. Diagnostic Pathology. 8(1). 37–37. 40 indexed citations

13.

Xiong, Jing, Fang Wei, Weirong Fang, et al.. (2008). Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp). Journal of Pharmacy and Pharmacology. 61(1). 89–94. 2 indexed citations

14.

Yu, Xiang, Yi Kong, Louis C. Doré, et al.. (2007). An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis. Journal of Clinical Investigation. 117(7). 1856–1865. 84 indexed citations

15.

Kong, Yi, Suiping Zhou, Anthony J. Kihm, et al.. (2004). Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia. Journal of Clinical Investigation. 114(10). 1457–1466. 7 indexed citations

16.

Gitler, Aaron D., Yi Kong, John Choi, et al.. (2004). Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia. Pediatric Research. 55(4). 581–584. 32 indexed citations

17.

Kong, Yi, et al.. (2004). [Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy].. PubMed. 40(5). 326–30.

18.

Kihm, Anthony J., Yi Kong, Hong Wei, et al.. (2002). An abundant erythroid protein that stabilizes free α-haemoglobin. Nature. 417(6890). 758–763. 221 indexed citations

19.

Kong, Yi & Martyn Lewis. (1988). Suppressor activation in autoimmune thyroiditis in mice.. PubMed. 5. 130–43. 2 indexed citations

20.

Kong, Yi, et al.. (1986). In vitro T cell proliferation and cytotoxicity in murine autoimmune thyroiditis.. PubMed. 53(1). 46–52. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact